Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 14, Issue 653, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-07-14
DOI
10.1126/scitranslmed.abl4106
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human Tumors
- (2021) Barbara Costa et al. Cancers
- Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages
- (2021) Natalia Ochocka et al. Nature Communications
- Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion
- (2021) Ester Gangoso et al. CELL
- Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
- (2021) Evan W. Weber et al. SCIENCE
- Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
- (2020) Florian Klemm et al. CELL
- A conserved dendritic-cell regulatory program limits antitumour immunity
- (2020) Barbara Maier et al. NATURE
- TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy
- (2020) Martina Molgora et al. CELL
- The Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages
- (2020) Ilaria Marigo et al. Cancer Discovery
- Microglia/macrophages express alternative proangiogenic factors depending on granulocyte content in human glioblastoma
- (2020) Anne Blank et al. JOURNAL OF PATHOLOGY
- Engineering cytokines and cytokine circuits
- (2020) Aileen W. Li et al. SCIENCE
- Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation
- (2019) Marta Joana Costa Jordão et al. SCIENCE
- Molecular responses to immune checkpoint blockade in glioblastoma
- (2019) Hirotaka Ito et al. NATURE MEDICINE
- Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets
- (2019) Luca Cassetta et al. CANCER CELL
- Metabolic Control of Dendritic Cell Functions: Digesting Information
- (2019) Stefanie K. Wculek et al. Frontiers in Immunology
- Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS–) vs. Alternatively Activated Macrophages
- (2019) Marco Orecchioni et al. Frontiers in Immunology
- Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
- (2019) E. Antonio Chiocca et al. Science Translational Medicine
- Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma
- (2019) Sangeeta Goswami et al. NATURE MEDICINE
- T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
- (2018) Karolina Woroniecka et al. CLINICAL CANCER RESEARCH
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens
- (2018) Giulia Escobar et al. Nature Communications
- Tet-On Systems For Doxycycline-inducible Gene Expression
- (2016) Atze T. Das et al. CURRENT GENE THERAPY
- IFN gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment
- (2016) M. Catarinella et al. EMBO Molecular Medicine
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
- (2015) D. A. Reardon et al. Cancer Immunology Research
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Genetic Engineering of Hematopoiesis for Targeted IFN- Delivery Inhibits Breast Cancer Progression
- (2014) G. Escobar et al. Science Translational Medicine
- Margin-Infiltrating CD20+ B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma
- (2013) J.-Y. Shi et al. CLINICAL CANCER RESEARCH
- Functional Neuroprotection and Efficient Regulation of GDNF Using Destabilizing Domains in a Rodent Model of Parkinson’s Disease
- (2013) Luis Quintino et al. MOLECULAR THERAPY
- Comparison of Different Suicide-Gene Strategies for the Safety Improvement of Genetically Manipulated T Cells
- (2012) Virna Marin et al. Human Gene Therapy Methods
- Identification of Hematopoietic Stem Cell-Specific miRNAs Enables Gene Therapy of Globoid Cell Leukodystrophy
- (2010) B. Gentner et al. Science Translational Medicine
- Tumor-Targeted Interferon-α Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis
- (2008) Michele De Palma et al. CANCER CELL
- Chemical control of protein stability and function in living mice
- (2008) Laura A Banaszynski et al. NATURE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started